References
- Daniels G. Cromer-related antigens—blood group determinants on decay-accelerating factor. Vox Sang 1989;56:205–11.
- Telen MJ, Hall SE, Green AM, Moulds JJ, Rosse WE Identification of human erythrocyte blood group antigens on decay-accelerating factor (DAF) and an erythrocyte phenotype negative for DAF. J Exp Med 1988;167:1993–8.
- Parsons SF, Spring FA, Merry AH, et al. Evidence that Cromer-related blood group antigens are carried on decay-accelerating factor (DAF) suggests that the Inab phenotype is a novel form of DAF deficiency (abstract). Proceedings of the XX Congress of the International Society for Blood Transfusion. British Blood Transfusion Society, Plymouth Grove, Manchester. 1988:116.
- Lubin DM, Lemons RS, LeBeau MM, et al. The gene encoding delay-accelerating factor (DAF) is located in the complement-regulatory locus on the long arm of chromosome 1. J Exp Med 1987;165:1731–6.
- Lewis M. Blood group terminology. Report of the ISBT Working Party on terminology for red cell surface antigens. Transfusion Today 1989;3:6–7.
- Knapp W, Dorken B, Rieber P, Schmidt RE, Stein H, von dem Borne AEGKr. CD antigens 1989. Blood 1989;74:1448–50.
- Telen MJ, Green AM. The Inab phenotype: characterization of the membrane protein and complement regulatory defect. Blood 1989;74:437–41.
- Merry AH, Rawlinson VI, Uchikawa M, Daha MR, Sim RB. Studies on the sensitivity to complement-mediated lysis of erythrocytes (Inab phenotype) with a deficiency of DAF (decay accelerating factor). Br J Haematol 1989;73:248–53.
- Poole J, Rausch V, Reid ME, Parsons SF, Liew YW. A new pro-posita with the rare Inab phenotype: serological and immunochemical studies (abstract). Transfusion 1989;29S:35S.
- Rosse WE The control of complement activation by the blood cells in paroxysmal nocturnal hemoglobinuria. Blood 1986;67:268–9.
- Ninomiya M, Abe T, Shichishima T, Terasawa T, Fujita T. Decayaccelerating factor (DAF) on the blood cell membrane in patients with paroxysmal nocturnal haemoglohinuria (PNH): measurement by enzyme-linked immunosorbent assay (ELISA). Br J Haematol 1988;69:81–7.
- Daniels GL, Tohyama H, Uchikawa M. A possible null phenotype in the Cromer blood group complex. Transfusion 1982;22:362–3.
- Walthers L, Salem M, Tesse J, Laird-Fryer B, Moulds JJ. The Inab phenotype: another example found (abstract). Transfusion 1983;23:423.
- Lin RC, Herman J, Henry L, Daniels GL. A family showing inheritance of the Inab phenotype. Transfusion 1988;28:427–9.
- Tate CG, Uchikawa M, Tanner MJA, et al. Studies on the defect which causes absence of decay accelerating factor (DAF) from the peripheral blood cells of an individual with the Inab phenotype. Biochem J 1989;261:489–93.
- Medof ME, Walter EI, Roberts WL, Hass R, Rosenberry TL. Decay accelerating factor of complement is anchored to cells by a C-terminal glycolipid. Biochem J 1986;25:6740–7.
- Low MG. Glycosyl-phosphatidylinositol: a versatile anchor for cell surface proteins. FASEB J 1989;3:1600–4.
- Caras IW, Davitz MA, Rhee L, Weddell G, Martin DN, Jr, Nussen-zweig V. Cloning of decay-accelerating factor suggests novel use of splicing to generate two proteins. Nature 1987;325: 545-9
- Medof ME, Lubin DM, Holers VM, et al. Cloning and characterization of cDNAs encoding the complete sequence of decayaccelerating factor of human complement. Proc Natl Acad Sci USA 1987;84:2007–11.
- Lubin DM, Krsek-Staples J, Pangburn MK, Atkinson JP. Biosynthesis and glycosylation of the human complement regulatory protein decay-accelerating factor. J Immunol 1986; 137:1629–35.
- Anstee DJ, Spring FA. Red cell membrane glycoproteins with a broad tissue distribution. Transfusion Medicine Reviews 1989;3:13–23.
- Medof ME, Kinoshita T, Silber R, Nussenzweig V. Amelioration of lytic abnormalities of paroxysmal nocturnal hemoglobinuria with decay-accelerating factor. Proc Natl Acad Sci USA 1985;82:2980–4.